Scotland will become the home of a new manufacturing innovation centre for the pharmaceutical industry.
The Medicines Manufacturing Innovation Centre (MMIP) is the first of it’s kind in the world, and will be built in Renfrewshire, west Scotland.
The £56mn (US$73.8mn) centre will focus on small molecule pharmaceutical and fine chemical manufacturing.
Through new technologies, the site aims to boost availability of medicines for patients.
“Our ambition is for patients worldwide to benefit from the accelerated adoption of emerging and novel medicine manufacturing technologies developed in the UK,” commented Andy Evans, Chair of the MMIP and Head of Macclesfield Site for AstraZeneca.
The facility will be developed next to the National Manufacturing Institute for Scotland in the Advanced Manufacturing Innovation District.
“This is a strong signal of intent from Government and the pharmaceutical industry that they are ready to get behind the UK as a global leader in medicines manufacturing,” stated CEO of the Association of the British Pharmaceutical Industry, Mike Thompson.
"Medicines manufacturing is no longer the siloed, labour intensive process of yesteryear.”
“This cutting edge centre instead provides a unique space for academics, research scientists and manufacturing partners to work side by side designing new ways to transition the medicines of the future out of development and in to the supply chain.”